Other OTC - Delayed Quote USD

Ambu A/S (AMBBY)

19.00 -0.75 (-3.80%)
At close: May 17 at 11:40 AM EDT
Loading Chart for AMBBY
DELL
  • Previous Close 19.75
  • Open 19.00
  • Bid --
  • Ask --
  • Day's Range 19.00 - 19.00
  • 52 Week Range 9.45 - 19.75
  • Volume 530
  • Avg. Volume 285
  • Market Cap (intraday) 5.06B
  • Beta (5Y Monthly) 0.87
  • PE Ratio (TTM) 95.00
  • EPS (TTM) 0.20
  • Earnings Date May 14, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Dec 15, 2021
  • 1y Target Est --

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

www.ambu.com

4,600

Full Time Employees

September 30

Fiscal Year Ends

Recent News: AMBBY

Performance Overview: AMBBY

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

AMBBY
24.18%
OMX Copenhagen 25 Index
7.58%

1-Year Return

AMBBY
17.87%
OMX Copenhagen 25 Index
5.09%

3-Year Return

AMBBY
50.26%
OMX Copenhagen 25 Index
0.00%

5-Year Return

AMBBY
52.69%
OMX Copenhagen 25 Index
14.80%

Compare To: AMBBY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AMBBY

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    5.05B

  • Enterprise Value

    5.09B

  • Trailing P/E

    94.34

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.92

  • Price/Book (mrq)

    6.19

  • Enterprise Value/Revenue

    6.88

  • Enterprise Value/EBITDA

    40.79

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.23%

  • Return on Assets (ttm)

    4.54%

  • Return on Equity (ttm)

    6.79%

  • Revenue (ttm)

    5.07B

  • Net Income Avi to Common (ttm)

    367M

  • Diluted EPS (ttm)

    0.20

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    387M

  • Total Debt/Equity (mrq)

    11.24%

  • Levered Free Cash Flow (ttm)

    507.38M

Research Analysis: AMBBY

Company Insights: AMBBY

Research Reports: AMBBY

People Also Watch